On the afternoon of October 13, the Shanghai Biopharmaceutical Industry Future Innovative Development Theme Forum was held in Zhangjiang, the core of Shanghai’s biopharmaceutical industry layout. As one of the important events of the first Shanghai International Biopharmaceutical Industry Week in 2021, the theme of this forum is “Gathering talents and enlightening the future”, focusing on the “stuck necks” and “dazzling brains” that restrict the high-quality development of Shanghai’s biomedical industry. Thinking, conceptual, and directional issues, discuss the key directions and key areas of the future innovation and development of the biomedical industry, such as the industrial environment, industrial direction, innovative ideas, and innovative talents.
Huang Hong, executive vice minister of the United Front Work Department of the Shanghai Municipal Party Committee, said in his speech that biomedicine is an important pillar of Shanghai’s strategic emerging industries and one of the three leading industries that Shanghai represents the country to participate in global cooperation and competition. In the future, if Shanghai wants to build a world-class biopharmaceutical industry cluster and innovation source, it must insist on “gathering talents from all over the world to use them”, creating a talent environment that recognizes, loves, and uses talents, and further expands the “circle of friends” in Shanghai’s biomedicine industry. I hope that everyone will spread the good environment and unlimited possibilities for the development of Shanghai’s biomedical industry, attract more outstanding biomedical talents to return to Shanghai, and form a high-level biomedical talent highland.
Shen Jun, Secretary of the Party Committee of Shanghai Municipal Economic Information Work, said in his speech that Shanghai is accelerating the process of becoming a world-class biomedical industry highland, and is actively creating an environment that is conducive to the bursting of innovative vitality and entrepreneurial power of industrial talents, and gathering at home and abroad. Talents from all walks of life enlighten the future high-quality and innovative development of Shanghai’s biopharmaceutical industry. Warmly expect global talents to come to Shanghai to innovate and start businesses, and welcome domestic and overseas biomedical industry talents to take root in Shanghai, display their talents, sow hope, create value, and realize dreams.
Zhang Qing, deputy director of the Shanghai Municipal Drug Administration, said in his speech that in 2021, Shanghai has newly approved 6 domestically produced innovative drugs of Category 1 which hit a record high, accounting for about 1/4 of the country’s total, including my country’s first specific target. To the small molecule inhibitor of MET kinase, and the first two cell therapy (CAR-T) products in China; 9 new products are added to the countryInnovative medicalThe special approval channel for devices accounts for about one-fifth of the country, which fully reflects Shanghai’s innovation and leadership capabilities in the field of biomedicine.
(Source: China Securities Net)
.